Brodalumab, CAS 1174395-19-7

Product Description: Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Papp KA, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012 Mar 29;366(13):1181-9./[2]Martin DA, et al. A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis. Arthritis Res Ther. 2013 Oct 25;15(5):R164.

CAS Number: 1174395-19-7

Molecular Weight: N/A

Compound Purity: 97.23

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Interleukin Related

• Artikelnummer: MEXHY-P9925-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9925-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK